A later amendment corrects this filing, so the terms on this page may be out of date. See the latest version (2026-09-03) →
What happened
Icure Pharmaceutical Incorporation updated the terms of a private placement (third-party allotment) to raise US$18.1M, about 24.5% of its market value.
For context, this raise equals about 24.5% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Private placement |
|---|---|
| Raise amount | US$18.1M |
| vs. market value | 24.5% |
| Filed | 2026-08-28, [Amended] Material event report (rights offering) |
| Source | DART rcept 20260828001021 → open original filing |
Versions of this filing
- 2026-06-29Original
- 2026-08-05Amendment 1
- 2026-08-12Amendment 2
- 2026-08-14Amendment 3
- 2026-08-18Amendment 4
- 2026-08-28Amendment 5
- 2026-08-28Amendment 6 (this page)
- 2026-09-03Amendment 7
Source: DART. Information only, not investment advice.